User profiles for Elsmarieke M. van de Giessen
Elsmarieke van de GiessenPost-doctoral researcher, Columbia University Medical Center Verified email at columbia.edu Cited by 3160 |
[HTML][HTML] Head-to-head comparison of PET and perfusion weighted MRI techniques to distinguish treatment related abnormalities from tumor progression in glioma
…, EM van de Giessen, N Tolboom, DE Oprea-Lager… - Cancers, 2023 - mdpi.com
Simple Summary This meta-analysis provides a first head-to-head comparison of PET and
perfusion weighted magnetic resonance imaging (PWI) in the surveillance of post-treatment …
perfusion weighted magnetic resonance imaging (PWI) in the surveillance of post-treatment …
Long COVID is associated with extensive in-vivo neuroinflammation on [18F]DPA-714 PET
…, RM Rikken, EM van de Giessen, ME den Hollander… - medRxiv, 2022 - medrxiv.org
A significant number of COVID-19 patients develop ‘long COVID’, a condition defined by
long-lasting debilitating, often neurological, symptoms. The pathophysiology of long COVID is …
long-lasting debilitating, often neurological, symptoms. The pathophysiology of long COVID is …
Striatal dopamine D2/3 receptor availability increases after long-term bariatric surgery-induced weight loss
…, BA de Weijer, EM van de Giessen… - European …, 2016 - Elsevier
In several studies reduced striatal dopamine D 2/3 receptor (D 2/3 R) availability was reported
in obese subjects compared to lean controls. Whether this is a reversible phenomenon …
in obese subjects compared to lean controls. Whether this is a reversible phenomenon …
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
…, I Law, S Morbelli, E van de Giessen… - The Lancet …, 2020 - thelancet.com
Various biomarkers are available to support the diagnosis of neurodegenerative diseases
in clinical and research settings. Among the molecular imaging biomarkers, amyloid-PET, …
in clinical and research settings. Among the molecular imaging biomarkers, amyloid-PET, …
Cognitive and Functional Change Over Time in Cognitively Healthy Individuals According to Alzheimer Disease Biomarker-Defined Subgroups
…, CE Teunissen, EM van de Giessen, AC Van Harten… - Neurology, 2024 - AAN Enterprises
Background and Objectives It is unclear to what extent cognitive outcome measures are
sensitive to capture decline in Alzheimer disease (AD) prevention trials. We aimed to analyze …
sensitive to capture decline in Alzheimer disease (AD) prevention trials. We aimed to analyze …
Neurobiological basis and risk factors of persistent fatigue and concentration problems after COVID-19: study protocol for a prospective case–control study (VeCosCO)
…, EM Van De Giessen, S Golla, CM Van Heugten… - BMJ open, 2023 - bmjopen.bmj.com
Introduction The risk factors for persistent fatigue and cognitive complaints after infection
with SARS-CoV-2 and the underlying pathophysiology are largely unknown. Both clinical …
with SARS-CoV-2 and the underlying pathophysiology are largely unknown. Both clinical …
α‐Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives
…, G van Dongen, E van de Giessen… - Movement …, 2022 - Wiley Online Library
α‐Synucleinopathies including idiopathic Parkinson's disease, dementia with Lewy bodies
and multiple systems atrophy share overlapping symptoms and pathological hallmarks. …
and multiple systems atrophy share overlapping symptoms and pathological hallmarks. …
Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study
…, E Van De Giessen, J Van Snellenberg… - JAMA …, 2015 - jamanetwork.com
… Author Contributions: Drs Slifstein and van de Giessen had full … Drs Slifstein and van de
Giessen contributed equally to this … Dr van de Giesson was supported by a Rubicon grant from …
Giessen contributed equally to this … Dr van de Giesson was supported by a Rubicon grant from …
[HTML][HTML] EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3
…, E van de Giessen, D Van Weehaeghe… - European journal of …, 2022 - Springer
The present procedural guidelines summarize the current views of the EANM Neuro-Imaging
Committee (NIC). The purpose of these guidelines is to assist nuclear medicine …
Committee (NIC). The purpose of these guidelines is to assist nuclear medicine …
[HTML][HTML] Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects
BA de Weijer, E van de Giessen, TA van Amelsvoort… - EJNMMI research, 2011 - Springer
… In the present study, we included obese women with a mean BMI of 47 kg/m 2 , and we were
able to … Barbara A de Weijer, Elsmarieke van de Giessen contributed equally to this work. …
able to … Barbara A de Weijer, Elsmarieke van de Giessen contributed equally to this work. …